SJS / TEN
Stop the Drug
6 questions
Question 1 · Recognising It
Correct answer: SJS/TEN — drug-induced epidermal necrosis, typically 1 to 4 weeks after the culprit drug
Why
Painful dusky rash with target lesions, mucositis, and Nikolsky-positive blistering, 1 to 4 weeks after a culprit drug.
- The classic culprits: allopurinol, anticonvulsants, sulfonamides — and he started allopurinol three weeks ago
- Nikolsky positive means the skin shears with lateral pressure — epidermal detachment
- Mucositis involving mouth, eyes and genitals is a defining feature and distinguishes it from most exanthems
- The pain is striking and out of proportion to how the rash looks early on, and is often the first clue
Key point
Painful rash plus mucositis plus Nikolsky positive, 1–4 weeks after a new drug. Allopurinol is a classic.
Question 2 · The One Thing
Correct answer: Stop every possible culprit drug — it is the one intervention proven to improve survival
Why
Identify and stop every possible culprit drug. It is the one intervention proven to improve survival.
- Not just the most likely one — every possible culprit, because continuing the drug while deliberating costs skin
- Document the allergy prominently
- Systemic immunomodulation — steroids, IVIg, ciclosporin — remains debated and is a specialist decision; none has the evidence base that drug withdrawal has
- The parallel is exact: in SJS/TEN as in DIC, treating the cause is what changes the outcome, and everything else is support
Key point
Stopping the drug is the treatment. It is the only intervention proven to improve survival.
Question 3 · Classifying
Correct answer: SJS/TEN overlap — 10 to 30% detachment — and SCORTEN should be calculated within 24 hours
Why
Classification is by percentage detachment: SJS under 10%, overlap 10 to 30%, TEN over 30%. At 18% he is in the overlap group.
- SCORTEN within 24 hours predicts mortality and guides the level of care
- Detachment above 10% is an escalation trigger for a burns unit or ITU discussion — so he qualifies
- The percentage is of detached or detachable skin, which includes Nikolsky-positive areas that have not yet sheared
- Mortality rises steeply with detachment area, which is why the classification is not academic
Key point
Under 10 SJS, 10–30 overlap, over 30 TEN — and over 10% means a burns unit conversation.
Question 4 · Support
Correct answer: Like a burn — IV fluids, warmth, opioid analgesia, non-adherent dressings, minimal handling — but NO prophylactic antibiotics
Why
Burns-style support: IV fluids, warmth, analgesia with opioids, non-adherent dressings, minimal handling. No prophylactic antibiotics.
- Skin pain is severe — treat it like a burn. Morphine, titrated
- Fluid requirements are less than for an equivalent-area burn — avoid overload, which is a specific and useful distinction
- Prophylactic antibiotics are avoided — treat proven infection only. They select resistant organisms in a patient who will be at high infection risk for weeks
- Minimal handling — every movement shears more skin
Key point
Treat it like a burn, but with less fluid and no prophylactic antibiotics.
Question 5 · The Eyes
Correct answer: Ocular involvement scars and blinds — hourly lubricants plus same-day ophthalmology prevent cicatricial blindness
Why
The eyes scar and blind. Acute conjunctival inflammation leads to symblepharon, lid margin scarring, corneal opacification and permanent visual loss if not treated early.
- Hourly ocular lubricants plus same-day ophthalmology
- Ocular involvement is an explicit escalation trigger
- The tragedy of SJS/TEN is that patients survive the acute illness and are left blind from an entirely preventable complication, because nobody looked at the eyes in week one
- Also: dermatology the same hour, and burns unit or ITU if detachment exceeds 10%
Key point
Same-day ophthalmology and hourly lubricants. Survivors go blind from the week nobody looked at their eyes.
Question 6 · Afterwards
Correct answer: MHRA Yellow Card, prominent allergy documentation with cross-reactant counselling, and consideration of HLA screening learning for at-risk groups
Why
Yellow Card, allergy documentation with cross-reactant counselling, and the HLA screening lesson.
- MHRA Yellow Card — severe cutaneous adverse reactions are exactly what the scheme exists to capture
- Cross-reactant counselling matters — a patient who reacted to one aromatic anticonvulsant may react to others; someone who reacted to allopurinol needs an alternative approach to gout
- HLA screening: HLA-B*58:01 before allopurinol in at-risk ethnicities, and HLA-B*15:02 before carbamazepine in some populations
- Rechallenge is potentially fatal, so the allergy record has to be unmissable — a discharge summary line is not enough
Key point
Yellow Card, unmissable allergy record, cross-reactants. Rechallenge can kill him.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.